Researchers at Vanderbilt University have discovered how insulin crosses the capillary endothelium to exit blood vessels and stimulate skeletal muscle cells—a major finding that may lead to new ways to reverse insulin resistance, ...
464
0
Teens today are more reluctant to smoke cigarettes than their counterparts nearly three decades ago, according to a study released this summer. But parents should hold their collective sigh of relief. The study, carried out ...
228
4
Researchers from Monash University have developed a new drug delivery strategy able to block pain within the nerve cells, in what could be a major development of an immediate and long lasting treatment for pain.
174
0
A mother's diet during pregnancy may have an effect on the composition of her baby's gut microbiome—the community of bacteria living in the gut—and the effect may vary by delivery mode, according to study published in ...
253
1
A new "artificial pancreas" being studied by the University of Melbourne could dramatically transform the lives of people with type 1 diabetes.
173
0
We used to think foetuses had no bacteria in their gastrointestinal tract (the gut) until they began to accumulate microbes (bacteria, viruses and other bugs) on their way through their mother's vagina.
123
0
A small team of researchers from the University of Colorado, the University of Haifa and University Paris Diderot has found that women sense less pain when holding the hand of a person they love. In their paper published ...
Researchers at the Spanish National Cancer Research Centre (CNIO) have developed an extremely powerful and versatile mouse model that will improve cancer research and accelerate pre-clinical testing of novel targeted therapies. ...
171
0
Patients with spinal fractures caused by tumors or osteoporosis usually undergo a procedure called kyphoplasty, where the fracture is filled with surgical cement. While kyphoplasty can stabilize the bone, cancer patients ...
144
0
Against the backdrop of increasing antibiotic resistance, the FORMAMP project has trialled nanotechnology-based delivery systems and antimicrobial peptides (AMPs), to deliver new tools in the fight against infectious diseases.
10
0
